International Urology and Nephrology

, Volume 45, Issue 3, pp 679–686 | Cite as

The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis

  • Jinhong Li
  • Lu Yang
  • Chunxiao Pu
  • Yin Tang
  • Haichao Yun
  • Ping Han
Urology - Original Paper

Abstract

Objectives

This systematic review determined whether the duloxetine can get more benefits versus placebo in managing women with stress urinary incontinence (SUI) all over the world.

Methods

We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing duloxetine with placebo in these patients. The eligible RCTs were identified from the following electronic databases: Cochrane CENTRAL, Medline and EMBASE. We treated the incontinence episode frequency (IEF) as the main outcome, and the secondary outcomes were cured, average voiding interval, incontinence quality of life (I-QOL), treatment-emergent adverse events (TEAEs) and discontinuation.

Results

The review contained ten trials including 5,738 women who were randomized to take duloxetine or placebo. All arms in individual trials were comparable for various baseline characteristics. Individual studies showed a significantly greater decrease in IEF than placebo group. The total IEF responders (defined as a woman who had at least a 50 % decrease in IEF with treatment) within the duloxetine-treated women were more than the placebo-treated women (52.5 vs. 33.7 %; RR = 1.56; 95 %CI, 1.46–1.66; p < 0.00001). TEAEs were commonly experienced by both two groups (62.7 vs. 45.3 %) though they were not critical.

Authors’ conclusions

Our meta-analysis showed that significant efficacy can be found in women treated with a certain dose of duloxetine. The adverse events like nausea, constipation, dry mouth, fatigue etc. are common.

Keywords

Stress urinary incontinence Duloxetine Medical management Systematic review Meta-analysis 

Abbreviations

SUI

Stress urinary incontinence

UI

Urinary incontinence

PFMT

Pelvic floor muscle training

SNRI

Serotonin and noradrenaline reuptake inhibitor

IEF

Incontinence episode frequency

I-QOL

Incontinence quality of life

TEAEs

Treatment-emergent adverse events

References

  1. 1.
    Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26PubMedCrossRefGoogle Scholar
  2. 2.
    Buckley BS, Lapitan MC, Epidemiology Committee of the Fourth International Consultation on Incontinence, Paris (2008) Prevalence of urinary incontinence in men, women, and children: current evidence-findings of the fourth international consultation on incontinence. Urology 2010(76):265–270Google Scholar
  3. 3.
    Imamura M, Abrams P, Bain C, et al. (2010) Systematic review and economic modeling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess 14:No.40Google Scholar
  4. 4.
    Abrams P, Cardozo L, Khoury S, Wein A (2005) International consultation on incontinence, 3rd edn. Health Publication Ltd, PlymouthGoogle Scholar
  5. 5.
    Mah SY, Lee KS, Choo MS et al (2006) Duloxetine versus placebo for the treatment of Korean women with stress predominant urinary incontinence. Korean J Urol 47(5):527–535CrossRefGoogle Scholar
  6. 6.
    Thor KB, Katofiasc MA (1995) Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloraloseanesthetized female cat. J Pharmacol Exp Ther 274:1014–1024PubMedGoogle Scholar
  7. 7.
    Lin AT, Sun MJ, Tai HL, et al. (2008) Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial. BMC Urology 8:2 (25 January 2008)Google Scholar
  8. 8.
    Millard RJ, Moore K, Rencken R et al (2004) Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int 93(3):311–318PubMedCrossRefGoogle Scholar
  9. 9.
    van Kerrebroeck P, Abrams P, Lange R et al (2004) Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 111:249–257PubMedCrossRefGoogle Scholar
  10. 10.
    Cardozo L, Drutz HP, Baygani SK et al (2004) Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 104(3):511–519PubMedCrossRefGoogle Scholar
  11. 11.
    Dmochowski RR, Miklos JR, Nortan PA et al (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170:1259–1263PubMedCrossRefGoogle Scholar
  12. 12.
    Norton PA, Zinner NR, Yalcin I et al (2002) Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40–48PubMedCrossRefGoogle Scholar
  13. 13.
    Higgins J, Green S (2005) editors. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. In the Cochrane Library, Issue 3, Chichester, United Kingdom: John Wiley and SonsGoogle Scholar
  14. 14.
    Mariappan P, Alhasso AA, Grant A et al (2009) Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults (Review). Cochrane Lib 1:1–56Google Scholar
  15. 15.
    Kinchen KS, Obenchain R, Swindle R (2005) Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. Int Urogynecol J 16:337–344CrossRefGoogle Scholar
  16. 16.
    Schagen van Leeuwen JH, Lange RR, Jonasson AF, Chen WJ et al (2008) Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. Maturitas 60:138–147PubMedCrossRefGoogle Scholar
  17. 17.
    Cardozo L, Lange R, Voss S, Beardsworth A et al (2010) Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin 26(2):253–261PubMedCrossRefGoogle Scholar
  18. 18.
    Pradhan A, Jain P, Latthe PM (2012) Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J 23:831–841PubMedCrossRefGoogle Scholar
  19. 19.
    Ho CP, Bhatia NN (2012) Development of stem cell therapy for stress urinary incontinence. Curr Opin Obstet Gynecol 24(5):311–317Google Scholar
  20. 20.
    Katofiasc MA, Nissen J, Audia JE et al (2002) Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 71:1227–1236PubMedCrossRefGoogle Scholar
  21. 21.
    Wyman JF, Fantl JA, McClish DK et al (1998) Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am J Obstet Gynecol 179(4):999–1007PubMedCrossRefGoogle Scholar
  22. 22.
    Kondo A, Yokoyama E, Koshiba K et al (1997) Bladder neck support prosthesis: a nonoperative treatment for stress or mixed urinary incontinence. J Uro 157(3):824–827CrossRefGoogle Scholar
  23. 23.
    Bodell DM, Leach GE (2002) Needle suspension procedures for female incontinence. Urol Clin North Am 29(3):575–584PubMedCrossRefGoogle Scholar
  24. 24.
    Rodriguez LV, Raz S (2003) Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaire. J Urol 170(3):857–863PubMedCrossRefGoogle Scholar
  25. 25.
    Itano N, Berman C, Rodriguez LV et al (2003) Polypropylene sling for the treatment of stress urinary incontinence: intermediate-term results. J Urol 169S:270Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Jinhong Li
    • 1
  • Lu Yang
    • 1
  • Chunxiao Pu
    • 1
  • Yin Tang
    • 1
  • Haichao Yun
    • 1
  • Ping Han
    • 1
  1. 1.Department of Urology, West China HospitalSichuan UniversityGuoxue Xiang, ChengduPeople’s Republic of China

Personalised recommendations